In some instances, the source transcript of an aeTSA was only slightly more abundant in the tumor than in the NAT; however, this reflects only the overall abundance of the entire transcript, and the peptide-coding sequences were in fact more abundant in the cancer (supplemental Fig. S8). This evidence concerns the gene BRD2 and cancer.